Evidence map›Paper›PMID 32608111›Full record

ArticleBritish journal of pharmacology2020

Interactions between cannabidiol and Δ

Lyndsey L Anderson, Ivan K Low, Iain S McGregor, Jonathon C Arnold

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Long-Term Treatment with Cannabidiol-EnrichedInternational journal of molecular sciences · 2023
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lyndsey L AndersonBrain and Mind Centre, The University of Sydney, Sydney, New South Wales, Australia.
Ivan K LowLambert Initiative for Cannabinoid Therapeutics, The University of Sydney, Sydney, New South Wales, Australia.
Iain S McGregorBrain and Mind Centre, The University of Sydney, Sydney, New South Wales, Australia.
Jonathon C ArnoldBrain and Mind Centre, The University of Sydney, Sydney, New South Wales, Australia.
University of Sydney · AU

Funding

Australian National Health and Medical Research Council (NHMRC)Lambert Initiative for Cannabinoid Therapeutics
6 · The paper itself

Abstract

background and purposeExtracts from the cannabis plant can dramatically improve the health of children suffering from refractory epilepsies such as Dravet syndrome. These extracts typically contain cannabidiol (CBD), a phytocannabinoid with well-documented anticonvulsant effects, but may also contain Δ EXPERIMENTAL APPROACH: Scn1a KEY

resultsAdministered alone, CBD (100 mg·kg CONCLUSION AND IMPLICATIONS: Low doses of Δ

Indexed as

CannabidiolDronabinolEpilepsies, MyoclonicAnimalsMiceMice, Inbred C57BLNAV1.1 Voltage-Gated Sodium ChannelSeizuresCannabidiolDronabinolNAV1.1 Voltage-Gated Sodium ChannelScn1a protein, mouse

Identifiers

PMID32608111
PMCPMC7443476
OpenAlexW3038799159

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.